Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Making Longitudinal Patient-Reported Outcomes Clinically Interpretable
February 2026
New guidance details valuable approaches to analyze longitudinal patient-reported outcomes when many patients die during follow-up.
Read more
18 Jan 2026
Breast Cancer Cryoablation Shows Low Recurrence
Six-year FROST trial data suggest cryoablation can durably control Stage I breast tumors, with low recurrence reported overall.
16 Jan 2026
A Cancer Strategy Built on Vulnerabilities
Synthetic lethality could counter cancer drug resistance by targeting tumor vulnerabilities that appear after treatment pressures.
14 Jan 2026
Medicaid Eligibility Restrictions May Reduce Cancer Screening
Medicaid eligibility restrictions may contribute 1 million missed cancer screenings and advanced stage diagnoses, models suggest.
10 Jan 2026
Neratinib Targets Vascular Inflammation in Atherosclerosis Models
Neratinib markedly reduced vascular inflammation and atherosclerosis in mice by targeting ASK1, boosting effects with rosuvastatin.
9 Jan 2026
Study Tests How Selenium Shapes Oxidative Stress
Selenium modulated redox signaling in renal cell carcinoma cells, shifting reactive oxygen species and survivability trajectories.
7 Jan 2026
Peripheral Inflammatory Cell Counts Linked to Depression
Peripheral inflammatory cell counts were linked to depression prevalence in NHANES adults with a history of solid tumors.
4 Jan 2026
High-Risk vs Very High-Risk Prostate Cancer Prognosis
Very high-risk prostate cancer predicted shorter survival than high-risk disease in nonmetastatic patients managed without surgery.
2 Jan 2026
Simplifying HPV Self-Collection Materials Builds Confidence
HPV self-collection education materials can boost screening confidence when language, visuals and inclusivity address key concerns.
Loading posts...
« Previous
1
2
3
4
…
33
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View